Davó Rubén, Felice Pietro, Pistilli Roberto, Barausse Carlo, Marti-Pages Carlos, Ferrer-Fuertes Ada, Ippolito Daniela Rita, Esposito Marco
Eur J Oral Implantol. 2018;11(2):145-161.
To compare the clinical outcome of immediately loaded cross-arch maxillary prostheses supported by zygomatic implants vs conventional implants placed in augmented bone.
In total, 71 edentulous patients with severely atrophic maxillas without sufficient bone volumes for placing dental implants, or when it was possible to place only two implants in the anterior area (minimal diameter 3.5 mm and length of 8 mm) and less than 4 mm of bone height subantrally, were randomised according to a parallel group design to receive zygomatic implants (35 patients) to be loaded immediately vs grafting with a xenograft, followed after 6 months of graft consolidation by placement of six to eight conventional dental implants submerged for 4 months (36 patients). For immediate loading, zygomatic implants had to be inserted with an insertion torque superior to 40 Ncm. Screw-retained metal reinforced acrylic provisional prostheses were provided, to be replaced by definitive Procera Implant Bridge Titanium prostheses (Nobel Biocare, Göteborg, Sweden), with ceramic or acrylic veneer materials 4 months after initial loading. Outcome measures were: prosthesis, implant and augmentation failures, any complications, quality of life (OHIP-14), patients' number of days with total or partial impaired activity, time to function and number of dental visits, assessed by independent assessors. Patients were followed up to 1 year after loading.
No augmentation procedure failed. Five patients dropped out from the augmentation group. Six prostheses could not be delivered or failed in the augmentation group vs one prosthesis in the zygomatic group, the difference being statistically significant (difference in proportions = -16.5%; P = 0.045; 95% CI: -0.34 to -0.01). Eight patients lost 35 implants in the augmentation group vs two patients who lost four zygomatic implants, the difference being statistically significant (difference in proportions = -20.1%; P = 0.037; 95% CI: -0.38 to -0.02). A total of 14 augmented patients were affected by 22 complications, vs 28 zygomatic patients (40 complications), the difference being statistically significant (difference in proportions = 34.8%; P = 0.005; 95% CI: 0.12 to 0.54). The 1-year OHIP-14 score was 3.93 ± 5.86 for augmented patients and 3.97 ± 4.32 for zygomatic patients with no statistically significant differences between groups (mean difference = 0.04; 95% CI: -2.56 to 2.65; P = 0.747). Both groups had significantly improved OHIP-14 scores from before rehabilitation (P < 0.001 for both augmented and zygomatic patients). On average, the number of days of total infirmity was 7.42 ± 3.17 for the augmented group and 7.17 ± 1.96 for the zygomatic group, the difference not being statistically significant (mean difference = -0.25; 95% CI: -1.52 to 1.02; P = 0.692). The number of days of partial infirmity were on average 14.24 ± 4.64 for the augmented group and 12.17 ± 3.82 for the zygomatic group, the difference being statistically significant (mean difference = -2.07; 95% CI: -4.12 to -0.02; P = 0.048). The mean number of days that needed to have a functional prosthesis was 444.32 ± 207.86 for augmented patients and 1.34 ± 2.27 for zygomatic patients, the difference being statistically significant (mean difference = -442.98; 95% CI: -513.10 to -372.86; P < 0.001). The average number of dental visits was 19.72 ± 12.22 for augmented patients and 15.12 ± 5.76 for zygomatic patients, the difference not being statistically significant (mean difference = -4.61; 95% CI: -9.31 to 0.92; P = 0.055).
Preliminary 1-year post-loading data suggest that immediately loaded zygomatic implants were associated with statistically significantly fewer prosthetic failures (one vs six patients), implant failures (two vs eight patients) and time needed to functional loading (1.3 days vs 444.3 days) when compared to augmentation procedures and conventionally loaded dental implants. Even if more complications were reported for zygomatic implants, they proved to be a better rehabilitation modality for severely atrophic maxillae. Long-term data are absolutely needed to confirm or dispute these preliminary results.
比较颧骨种植体支持的即刻负重上颌跨牙弓修复体与植入增强骨中的传统种植体的临床效果。
总共71例无牙患者,上颌严重萎缩,没有足够的骨量来植入牙种植体,或者仅在前牙区能够植入两颗种植体(最小直径3.5mm,长度8mm)且上颌窦下骨高度小于4mm,根据平行组设计随机分组,35例患者接受颧骨种植体并即刻负重,36例患者接受异种骨移植,在移植巩固6个月后植入6至8颗传统牙种植体并埋入4个月。对于即刻负重,颧骨种植体的植入扭矩必须超过40Ncm。提供螺丝固位的金属增强丙烯酸临时修复体,在初始负重4个月后用确定性的Procera种植体桥钛修复体(诺贝尔生物科技公司,瑞典哥德堡)替换,采用陶瓷或丙烯酸贴面材料。观察指标包括:修复体、种植体和植骨失败情况、任何并发症、生活质量(OHIP-14)、患者完全或部分活动受限的天数、功能恢复时间和看牙次数,由独立评估者进行评估。患者在负重后随访1年。
没有植骨手术失败。5例患者退出植骨组。植骨组有6个修复体无法交付或失败,而颧骨种植体组有1个修复体失败,差异有统计学意义(比例差异=-16.5%;P=o.o45;95%可信区间:-0.34至-0.01)。植骨组8例患者丢失35颗种植体,而颧骨种植体组2例患者丢失4颗颧骨种植体,差异有统计学意义(比例差异=-20.1%;P=0.037;95%可信区间:-0.38至-0.02)。总共14例植骨患者出现22种并发症,而28例颧骨种植体患者出现40种并发症,差异有统计学意义(比例差异=34.8%;P=0.005;95%可信区间:0.12至0.54)。植骨患者1年的OHIP-14评分为3.93±5.86,颧骨种植体患者为-3.97±4.32,两组之间无统计学显著差异(平均差异=0.04;95%可信区间:-2.56至2.65;P=0.747)。两组患者康复前的OHIP-14评分均有显著改善(植骨患者和颧骨种植体患者P均<0.001)。平均而言,植骨组完全虚弱的天数为7.42±3.17,颧骨种植体组为7.17±1.96,差异无统计学意义(平均差异=-0.25;95%可信区间:-1.52至1.02;P=0.692)·植骨组部分虚弱的天数平均为14.24±4.64,颧骨种植体组为12.17±3.82,差异有统计学意义(平均差异=-2.0?;95%可信区间:-4.12至-0.02;P=0.048)。植骨患者拥有功能性修复体所需的平均天数为444.32±207.86,颧骨种植体患者为1.34±2.27,差异有统计学意义(平均差异=-442.98;95%可信区间:-513.10至-372.86;P<0.001)。植骨患者的平均看牙次数为19.72±12.22,颧骨种植体患者为15.12±5.76,差异无统计学意义(平均差异=-4.61;95%可信区间:-9.31至0.92;P=0.055)。
初步的1年负重后数据表明,与植骨手术和传统负重牙种植体相比,即刻负重的颧骨种植体在统计学上显著减少了修复体失败(1例对6例患者)、种植体失败(2例对8例患者)以及达到功能负重所需的时间(1.3天对444.3天)。即使颧骨种植体报告的并发症更多,但它们被证明是严重萎缩上颌骨更好的修复方式。绝对需要长期数据来证实或反驳这些初步结果。